During the past decade, Yale University MS Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yale University MS Center" #1 sponsor was "Acorda Therapeutics" with 3 trials, followed by "Artielle ImmunoTherapeutics" with 1 trials sponsored, "Cognition Pharmaceuticals, LLC" with 1 trials sponsored, "Elan Pharmaceuticals" with 1 trials sponsored and "Genzyme, a Sanofi Company" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale University MS Center" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Immune Tolerance Network (ITN)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Yale University MS Center" are "Multiple Sclerosis" (7 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Cognition Disorders" (1 trials), "Multiple Sclerosis, Chronic Progressive" (1 trials) and "Muscle Spasticity" (1 trials). Many other conditions were trialed in "Yale University MS Center" in a lesser frequency.

Most popular intervention types in "Yale University MS Center" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Fampridine-SR" (2 trials), "10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)" (1 trials), "15 mg fampridine-SR (4-aminopyridine, 4-AP)" (1 trials) and "20 mg fampridine-SR (4-aminopyridine, 4-AP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale University MS Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Yale University MS Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Yale University MS Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale University MS Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".